Eleonora Baldonero
Research Subjects
Eleonora Baldonero has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Nicoletta Ciccarelli
Department of Theoretical and Applied Sciences, eCampus University, 22060 Novedrate, Italy
9 shared publications - Massimiliano Fabbiani
Department of Medical Biotechnologies University of Siena Siena Italy
7 shared publications - Roberto Cauda
Dipartimento di Sicurezza e Bioetica, Sezione di Malattie Infettive, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
7 shared publications - Manuela Colafigli
Infectious Dermatology and Allergology Unit, IFO S. Gallicano Institute (IRCCS), Rome, Italy
4 shared publications - Andrea De Luca
Division of Infectious Diseases, Siena University Hospital, Siena, Italy
3 shared publications - Enrica Tamburrini
Institute of Clinical Infectious Diseases, Catholic University of Sacred Heart, Rome, Italy
3 shared publications
Latest Publications
- Open Access
- 5 June 2014
- Published by Wiley in Behavioural Neurology
- Vol. 2014, 1-8
Posterior AD-Type Pathology: Cognitive Subtypes Emerging from a Cluster Analysis
Background. “Posterior shift” of the neuropathological changes of Alzheimer's disease (AD) produces a syndrome (posterior cortical atrophy) (PCA) dominated by high-level visual deficits.Objective. To explore in patients with AD-type pathology whether a data-driven analysis (cluster analysis) based on neuropsychological findings resulted in the emergence of different subgroups of patients; in particular to find out whether it was possible to identify patients with visuospatial deficits consistent with the hypothesis that PCA is a “dorsal stream” syndrome or, rather, whether there were subgroups of patients with different types of impairment within the high-level visual domain.Methods. 23 PCA and 16 DAT patients were studied. By a principal component analysis performed on a wide range of neuropsychological tasks, 15 variables were obtained that loaded onto five main factors (memory, language, perceptual, visuospatial, and calculation) which entered a hierarchical cluster analysis.Results. Four clusters of cognitive impairment emerged: visuospatial/perceptual, memory, perceptual/calculation, and language. Only in the first cluster a visuospatial deficit clearly emerged.Conclusions. AD pathology produces not only variants dominated by memory (DAT) and, to a lesser extent, visuospatial deficit (PCA), but also other distinct syndromic subtypes with disorders in visual perception and language which reflect a different vulnerability of specific functional networks.
- 5 June 2014
- Published by Wiley in Behavioural Neurology
- Vol. 2014, 1-8
Open AccessPosterior AD-Type Pathology: Cognitive Subtypes Emerging from a Cluster Analysis
Background. “Posterior shift” of the neuropathological changes of Alzheimer's disease (AD) produces a syndrome (posterior cortical atrophy) (PCA) dominated by high-level visual deficits.Objective. To explore in patients with AD-type pathology whether a data-driven analysis (cluster analysis) based on neuropsychological findings resulted in the emergence of different subgroups of patients; in particular to find out whether it was possible to identify patients with visuospatial deficits consistent with the hypothesis that PCA is a “dorsal stream” syndrome or, rather, whether there were subgroups of patients with different types of impairment within the high-level visual domain.Methods. 23 PCA and 16 DAT patients were studied. By a principal component analysis performed on a wide range of neuropsychological tasks, 15 variables were obtained that loaded onto five main factors (memory, language, perceptual, visuospatial, and calculation) which entered a hierarchical cluster analysis.Results. Four clusters of cognitive impairment emerged: visuospatial/perceptual, memory, perceptual/calculation, and language. Only in the first cluster a visuospatial deficit clearly emerged.Conclusions. AD pathology produces not only variants dominated by memory (DAT) and, to a lesser extent, visuospatial deficit (PCA), but also other distinct syndromic subtypes with disorders in visual perception and language which reflect a different vulnerability of specific functional networks.
- 1 May 2014
- Published by SAGE Publications in Antiviral Therapy
- Vol. 20 (4) , 441-447
Antiretroviral Neuropenetration Scores Better Correlate with Cognitive Performance of HIV-Infected Patients after Accounting for drug Susceptibility
Background: The aim of the study was to explore how viral resistance and antiretroviral central nervous system (CNS) penetration could impact on cognitive performance of HIV-infected patients. Methods: We performed a multicentre cross-sectional study enrolling HIV-infected patients undergoing neuropsychological testing, with a previous genotypic resistance test on plasma samples. CNS penetration-effectiveness (CPE) scores and genotypic susceptibility scores (GSS) were calculated for each regimen. A composite score (CPE-GSS) was then constructed. Factors associated with cognitive impairment were investigated by logistic regression analysis. Results: A total of 215 patients were included. Mean CPE was 7.1 (95% CI 6.9, 7.3) with 206 (95.8%) patients showing a CPE≥6. GSS correction decreased the CPE value in 21.4% (mean 6.5, 95% CI 6.3, 6.7), 26.5% (mean 6.4, 95% CI 6.1, 6.6) and 24.2% (mean 6.4, 95% CI 6.2, 6.6) of subjects using ANRS, HIVDB and REGA rules, respectively. Overall, 66 (30.7%) patients were considered cognitively impaired. No significant association could be demonstrated between CPE and cognitive impairment. However, higher GSS-CPE was associated with a lower risk of cognitive impairment (CPE-GSS ANRS odds ratio 0.75, P=0.022; CPE-GSS HIVDB odds ratio 0.77, P=0.038; CPE-GSS REGA odds ratio 0.78, P=0.038). Overall, a cutoff of CPE-GSS≥5 seemed the most discriminatory according to each different interpretation system. Conclusions: GSS-corrected CPE score showed a better correlation with neurocognitive performance than the standard CPE score. These results suggest that antiretroviral drug susceptibility, besides drug CNS penetration, can play a role in the control of HIV-associated neurocognitive disorders.
- 1 May 2014
- Published by SAGE Publications in Antiviral Therapy
- Vol. 20 (4) , 441-447
Antiretroviral Neuropenetration Scores Better Correlate with Cognitive Performance of HIV-Infected Patients after Accounting for drug Susceptibility
Background: The aim of the study was to explore how viral resistance and antiretroviral central nervous system (CNS) penetration could impact on cognitive performance of HIV-infected patients. Methods: We performed a multicentre cross-sectional study enrolling HIV-infected patients undergoing neuropsychological testing, with a previous genotypic resistance test on plasma samples. CNS penetration-effectiveness (CPE) scores and genotypic susceptibility scores (GSS) were calculated for each regimen. A composite score (CPE-GSS) was then constructed. Factors associated with cognitive impairment were investigated by logistic regression analysis. Results: A total of 215 patients were included. Mean CPE was 7.1 (95% CI 6.9, 7.3) with 206 (95.8%) patients showing a CPE≥6. GSS correction decreased the CPE value in 21.4% (mean 6.5, 95% CI 6.3, 6.7), 26.5% (mean 6.4, 95% CI 6.1, 6.6) and 24.2% (mean 6.4, 95% CI 6.2, 6.6) of subjects using ANRS, HIVDB and REGA rules, respectively. Overall, 66 (30.7%) patients were considered cognitively impaired. No significant association could be demonstrated between CPE and cognitive impairment. However, higher GSS-CPE was associated with a lower risk of cognitive impairment (CPE-GSS ANRS odds ratio 0.75, P=0.022; CPE-GSS HIVDB odds ratio 0.77, P=0.038; CPE-GSS REGA odds ratio 0.78, P=0.038). Overall, a cutoff of CPE-GSS≥5 seemed the most discriminatory according to each different interpretation system. Conclusions: GSS-corrected CPE score showed a better correlation with neurocognitive performance than the standard CPE score. These results suggest that antiretroviral drug susceptibility, besides drug CNS penetration, can play a role in the control of HIV-associated neurocognitive disorders.
- 1 May 2014
- Published by SAGE Publications in Antiviral Therapy
- Vol. 20 (4) , 433-440
Baseline CD4 + T-cell Count and Cardiovascular Risk Factors Predict the Evolution of Cognitive Performance During 2-Year follow-up in HIV-Infected Patients
Background: The aim of our study was to better understand the dynamics between cardiovascular risk factors and immunological parameters in the evolution of cognitive performance in HIV+ patients. Methods: We conducted a prospective longitudinal study, consecutively enrolling asymptomatic HIV+ subjects during routine outpatient visits at two clinical centres. At baseline and after 2 years, all patients underwent a comprehensive neuropsychological battery. Common carotid intima-media thickness (cIMT) was also measured. Results: A total of 150 patients completed the study (77% males, median age 46 years, 20% with past AIDS-defining events, 95% on cART, 88% with HIV-RNA+ T-cell count (OR 0.80 per 100 cells/ml higher; 95% CI 0.66, 0.97; P=0.026) was found to be a protective factor, adjusting for the presence of a memory impairment at baseline. When the analysis was restricted to patients who did not change antiretroviral therapy during the study period ( n=109), baseline cIMT (OR 14.6 per 0.1 mm higher; 95% CI 1.1, 189.9; P=0.041) also emerged as an independent risk factor for memory impairment at 2-year follow-up. Conclusions: Immunological parameters and cardiovascular risk factors are independently associated with the evolution of cognitive status in HIV+ patients.
- 1 May 2014
- Published by SAGE Publications in Antiviral Therapy
- Vol. 20 (4) , 433-440
Baseline CD4 + T-cell Count and Cardiovascular Risk Factors Predict the Evolution of Cognitive Performance During 2-Year follow-up in HIV-Infected Patients
Background: The aim of our study was to better understand the dynamics between cardiovascular risk factors and immunological parameters in the evolution of cognitive performance in HIV+ patients. Methods: We conducted a prospective longitudinal study, consecutively enrolling asymptomatic HIV+ subjects during routine outpatient visits at two clinical centres. At baseline and after 2 years, all patients underwent a comprehensive neuropsychological battery. Common carotid intima-media thickness (cIMT) was also measured. Results: A total of 150 patients completed the study (77% males, median age 46 years, 20% with past AIDS-defining events, 95% on cART, 88% with HIV-RNA+ T-cell count (OR 0.80 per 100 cells/ml higher; 95% CI 0.66, 0.97; P=0.026) was found to be a protective factor, adjusting for the presence of a memory impairment at baseline. When the analysis was restricted to patients who did not change antiretroviral therapy during the study period ( n=109), baseline cIMT (OR 14.6 per 0.1 mm higher; 95% CI 1.1, 189.9; P=0.041) also emerged as an independent risk factor for memory impairment at 2-year follow-up. Conclusions: Immunological parameters and cardiovascular risk factors are independently associated with the evolution of cognitive status in HIV+ patients.
- 1 November 2013
- Published by American Psychological Association (APA) in Neuropsychology
- Vol. 27 (6) , 628-641
Visual short-term store can compensate for a defective phonological short-term store in patients with apraxia of speech.
The aim of the study was to investigate whether, within the phonological short-term memory (STM) system, speech articulation disorders primarily due to cortical damage are associated with deficits in the phonological recoding of visual-verbal material, and whether the visual short-term store (STS) can compensate for inefficient access to the phonological STS, as suggested in previous reports. Two patients (AE and TM) with apraxia of speech due to atrophic cerebral damage were administered a battery of tasks devised to explore the organization of the phonological STM. AE's span was normal and TM's span was markedly reduced. Phonological similarity and word-length effects: Both patients showed the effects in visual presentation; the effect was less evident in verbal presentation. This suggests a phonological STS disorder and preserved rehearsal/phonological recoding, consistently with involvement of the left parietal regions, which was documented by the MRI in both patients. Unexpectedly, TM had a longer span for similar than for dissimilar words in visually presented stimuli. Silent phonology (on written material): At variance with controls, stress assignment improved during unattended speech both in AE and TM, while in both patients and controls a detrimental effect of unattended speech was documented in the initial sound task. To account for this unusual pattern of results, we hypothesized that whenever possible, AE and TM adopt the strategy that takes advantage of the visual STM store to compensate for a defective phonological STS.
- 1 November 2013
- Published by American Psychological Association (APA) in Neuropsychology
- Vol. 27 (6) , 628-641
Visual short-term store can compensate for a defective phonological short-term store in patients with apraxia of speech.
The aim of the study was to investigate whether, within the phonological short-term memory (STM) system, speech articulation disorders primarily due to cortical damage are associated with deficits in the phonological recoding of visual-verbal material, and whether the visual short-term store (STS) can compensate for inefficient access to the phonological STS, as suggested in previous reports. Two patients (AE and TM) with apraxia of speech due to atrophic cerebral damage were administered a battery of tasks devised to explore the organization of the phonological STM. AE's span was normal and TM's span was markedly reduced. Phonological similarity and word-length effects: Both patients showed the effects in visual presentation; the effect was less evident in verbal presentation. This suggests a phonological STS disorder and preserved rehearsal/phonological recoding, consistently with involvement of the left parietal regions, which was documented by the MRI in both patients. Unexpectedly, TM had a longer span for similar than for dissimilar words in visually presented stimuli. Silent phonology (on written material): At variance with controls, stress assignment improved during unattended speech both in AE and TM, while in both patients and controls a detrimental effect of unattended speech was documented in the initial sound task. To account for this unusual pattern of results, we hypothesized that whenever possible, AE and TM adopt the strategy that takes advantage of the visual STM store to compensate for a defective phonological STS.
- 10 July 2013
- Published by Springer Nature in Infection
- Vol. 41 (6) , 1103-1109
Comparison of cognitive performance in HIV or HCV mono-infected and HIV–HCV co-infected patients
Our aim was to explore the interplay between human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections in the expression of cognitive disorders. We performed a multi-centre cross-sectional study, enrolling three groups of asymptomatic outpatients matched for age and education: (1) HIV mono-infected; (2) HCV mono-infected; (3) HIV–HCV co-infected. All subjects were subjected to the Zung depression scale and a comprehensive neuropsychological battery. A total of 50 patients for each group were enrolled. Patients in the three groups did not significantly differ in the main common demographic and clinical characteristics, except for a lower proportion of past injecting drug use (IDU) in group 1 (4 %) in comparison to groups 2 (38 %, p < 0.001) and 3 (78 %, p < 0.001), a longer duration of HIV infection in group 3 in comparison to group 1 (p < 0.001) and a longer duration of HCV infection in group 3 in comparison to group 2 (p = 0.028). Overall, 39.3 % of patients showed minor cognitive impairment, with a higher proportion in group 3 (54 %) when compared to groups 1 (28 %, p = 0.015) or 2 (36 %, p = 0.108). Patients in group 3 [odds ratio (OR) 3.35, p = 0.038 when compared to group 1] and those with higher depression scores (OR 1.05, p = 0.017) showed an increased risk of cognitive impairment after adjusting for education and past injection drug use. In particular, group 3 showed worse performance in psychomotor speed tasks when compared to group 1 (p = 0.033). A worse cognitive performance in HIV–HCV co-infected patients was observed, suggesting an additive role of the two viruses in the pathogenesis of cognitive disorders.
- 10 July 2013
- Published by Springer Nature in Infection
- Vol. 41 (6) , 1103-1109
Comparison of cognitive performance in HIV or HCV mono-infected and HIV–HCV co-infected patients
Our aim was to explore the interplay between human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections in the expression of cognitive disorders. We performed a multi-centre cross-sectional study, enrolling three groups of asymptomatic outpatients matched for age and education: (1) HIV mono-infected; (2) HCV mono-infected; (3) HIV–HCV co-infected. All subjects were subjected to the Zung depression scale and a comprehensive neuropsychological battery. A total of 50 patients for each group were enrolled. Patients in the three groups did not significantly differ in the main common demographic and clinical characteristics, except for a lower proportion of past injecting drug use (IDU) in group 1 (4 %) in comparison to groups 2 (38 %, p < 0.001) and 3 (78 %, p < 0.001), a longer duration of HIV infection in group 3 in comparison to group 1 (p < 0.001) and a longer duration of HCV infection in group 3 in comparison to group 2 (p = 0.028). Overall, 39.3 % of patients showed minor cognitive impairment, with a higher proportion in group 3 (54 %) when compared to groups 1 (28 %, p = 0.015) or 2 (36 %, p = 0.108). Patients in group 3 [odds ratio (OR) 3.35, p = 0.038 when compared to group 1] and those with higher depression scores (OR 1.05, p = 0.017) showed an increased risk of cognitive impairment after adjusting for education and past injection drug use. In particular, group 3 showed worse performance in psychomotor speed tasks when compared to group 1 (p = 0.033). A worse cognitive performance in HIV–HCV co-infected patients was observed, suggesting an additive role of the two viruses in the pathogenesis of cognitive disorders.
- Open Access
- 27 February 2013
- Published by Springer Nature in BMC Psychology
- Vol. 1 (1) , 3
Evaluation of emotion processing in HIV-infected patients and correlation with cognitive performance
Facial emotion recognition depends on cortical and subcortical networks. HIV infection of the central nervous system can damage these networks, leading to impaired facial emotion recognition. We performed a cross-sectional single cohort study consecutively enrolling HIV + subjects during routine outpatient visits. Age, gender and education-matched HIV-negative healthy individuals were also selected. Subjects were submitted to a Facial Emotion Recognition Test, which assesses the ability to recognize six basic emotions (disgust, anger, fear, happiness, surprise, sadness). The score for each emotion and a global score (obtained by summing scores for each emotion) were analyzed. General cognitive status of patients was also assessed. A total of 49 HIV + and 20 HIV − subjects were enrolled. On the Facial Emotion Recognition Test, ANOVA revealed a significantly lower performance of HIV + subjects than healthy controls in recognizing fear. Moreover, fear facial emotion recognition was directly correlated with Immediate Recall of Rey Words. The lower the patients’ neurocognitive performance the less accurate they were in recognizing happiness. AIDS-defining events were negatively related to the correct recognition of happiness. Fear recognition deficit in HIV + patients might be related to the impaired function of neural networks in the frontostriatal system. AIDS events, including non-neurological ones, may have a negative effect on this system. Inclusion of an emotion recognition test in the neuropsychological test battery could help clinicians during the long term management of HIV-infected patients, to better understand the cognitive mechanisms involved in the reduction of emotion recognition ability and the impact of this impairment on daily life.
- 27 February 2013
- Published by Springer Nature in BMC Psychology
- Vol. 1 (1) , 3
Open AccessEvaluation of emotion processing in HIV-infected patients and correlation with cognitive performance
Facial emotion recognition depends on cortical and subcortical networks. HIV infection of the central nervous system can damage these networks, leading to impaired facial emotion recognition. We performed a cross-sectional single cohort study consecutively enrolling HIV + subjects during routine outpatient visits. Age, gender and education-matched HIV-negative healthy individuals were also selected. Subjects were submitted to a Facial Emotion Recognition Test, which assesses the ability to recognize six basic emotions (disgust, anger, fear, happiness, surprise, sadness). The score for each emotion and a global score (obtained by summing scores for each emotion) were analyzed. General cognitive status of patients was also assessed. A total of 49 HIV + and 20 HIV − subjects were enrolled. On the Facial Emotion Recognition Test, ANOVA revealed a significantly lower performance of HIV + subjects than healthy controls in recognizing fear. Moreover, fear facial emotion recognition was directly correlated with Immediate Recall of Rey Words. The lower the patients’ neurocognitive performance the less accurate they were in recognizing happiness. AIDS-defining events were negatively related to the correct recognition of happiness. Fear recognition deficit in HIV + patients might be related to the impaired function of neural networks in the frontostriatal system. AIDS events, including non-neurological ones, may have a negative effect on this system. Inclusion of an emotion recognition test in the neuropsychological test battery could help clinicians during the long term management of HIV-infected patients, to better understand the cognitive mechanisms involved in the reduction of emotion recognition ability and the impact of this impairment on daily life.
- 18 November 2012
- Published by Springer Nature in Neurological Sciences
- Vol. 34 (7) , 1207-1213
Neuropsychological features of patients with Parkinson’s disease and impulse control disorders
Impulse control disorders (ICDs) are frequent in Parkinson’s disease (PD). Aim of the present study was to investigate cognition and behaviour in PD patients with and without ICDs, in order to identify potential early clinical features which might be associated to the development of ICDs. We recruited 17 PD patients with ICDs and 17 without ICDs, matched for several clinical variables, without clinically significant cognitive deficits. Assessments included behavioural scales and a neuropsychological battery, including the Iowa Gambling Task (IGT). In patients with ICDs, the total score of the BIS and the Motor Impulsivity subscore were significantly higher than in patients without ICDs. In patients with ICDs, we observed only statistical trends towards a worse performance on neuropsychological tasks (go-no-go subtest of the Frontal Assessment Battery, oral verb naming task, copying of drawings with landmarks) sensitive to frontal lobe dysfunction (FLD) and on the IGT (loss of a greater amount of money, more risky choices). As compared to patients without ICDs, they reported a more than threefold number of errors on the interference subtest of Stroop test, which is also sensitive to FLD. Although this study did not show any significant difference between PD patients presenting ICDs as compared with patients without ICDs on neuropsychological variables, some preliminary evidence was detected suggesting a trend toward a worse performance of the PD-ICD group on few neuropsychological tasks which are at least partially sensitive to frontal lobe dysfunction, including tasks sensitive to dysfunction of ventral fronto-striatal loops.
- 18 November 2012
- Published by Springer Nature in Neurological Sciences
- Vol. 34 (7) , 1207-1213
Neuropsychological features of patients with Parkinson’s disease and impulse control disorders
Impulse control disorders (ICDs) are frequent in Parkinson’s disease (PD). Aim of the present study was to investigate cognition and behaviour in PD patients with and without ICDs, in order to identify potential early clinical features which might be associated to the development of ICDs. We recruited 17 PD patients with ICDs and 17 without ICDs, matched for several clinical variables, without clinically significant cognitive deficits. Assessments included behavioural scales and a neuropsychological battery, including the Iowa Gambling Task (IGT). In patients with ICDs, the total score of the BIS and the Motor Impulsivity subscore were significantly higher than in patients without ICDs. In patients with ICDs, we observed only statistical trends towards a worse performance on neuropsychological tasks (go-no-go subtest of the Frontal Assessment Battery, oral verb naming task, copying of drawings with landmarks) sensitive to frontal lobe dysfunction (FLD) and on the IGT (loss of a greater amount of money, more risky choices). As compared to patients without ICDs, they reported a more than threefold number of errors on the interference subtest of Stroop test, which is also sensitive to FLD. Although this study did not show any significant difference between PD patients presenting ICDs as compared with patients without ICDs on neuropsychological variables, some preliminary evidence was detected suggesting a trend toward a worse performance of the PD-ICD group on few neuropsychological tasks which are at least partially sensitive to frontal lobe dysfunction, including tasks sensitive to dysfunction of ventral fronto-striatal loops.
- 30 October 2012
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 60 (11) , 2048-2055
Effect of Aging and Human Immunodeficiency Virus Infection on Cognitive Abilities
Objectives: To explore the combined effects of aging and human immunodeficiency virus ( HIV ) infection on cognitive decay. Design: Cross‐sectional, single‐cohort study. Setting: Institute of Cl inical I nfectious D iseases, C atholic U niversity of the S acred H eart, R ome, I taly. Participants: One hundred fifty‐three asymptomatic HIV ‐positive ( HIV +) outpatients (20% aged ≥ 60) and an age‐ and education‐matched control population of 39 HIV ‐negative individuals. Measurements: A neuropsychological investigation was conducted to compare four groups of participants classified on the basis of HIV serostatus and age (<60 vs ≥60). The effects of age and HIV infection on neuropsychological performance were analyzed using a two‐by‐two factorial analysis of variance. Demographic and clinical variables associated with neuropsychological performance were identified using linear regression analysis in the HIV + population. Results: HIV infection and aging had significant negative effects on cognitive performance, but no significant interaction was observed between these two factors. Although older HIV + participants had worse cognitive performance, they showed no distinct cognitive pattern from younger HIV + participants. Moreover, younger HIV + participants' performance on memory tasks was qualitatively and quantitatively comparable with that of older HIV − participants, despite the dramatic age difference. Conclusion: Aging and HIV might be additive factors in the expression of cognitive decline. As the HIV + population ages, routine neuropsychological examinations could help clinicians better understand and manage the expression of cognitive impairment.
- 30 October 2012
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 60 (11) , 2048-2055
Effect of Aging and Human Immunodeficiency Virus Infection on Cognitive Abilities
Objectives: To explore the combined effects of aging and human immunodeficiency virus ( HIV ) infection on cognitive decay. Design: Cross‐sectional, single‐cohort study. Setting: Institute of Cl inical I nfectious D iseases, C atholic U niversity of the S acred H eart, R ome, I taly. Participants: One hundred fifty‐three asymptomatic HIV ‐positive ( HIV +) outpatients (20% aged ≥ 60) and an age‐ and education‐matched control population of 39 HIV ‐negative individuals. Measurements: A neuropsychological investigation was conducted to compare four groups of participants classified on the basis of HIV serostatus and age (<60 vs ≥60). The effects of age and HIV infection on neuropsychological performance were analyzed using a two‐by‐two factorial analysis of variance. Demographic and clinical variables associated with neuropsychological performance were identified using linear regression analysis in the HIV + population. Results: HIV infection and aging had significant negative effects on cognitive performance, but no significant interaction was observed between these two factors. Although older HIV + participants had worse cognitive performance, they showed no distinct cognitive pattern from younger HIV + participants. Moreover, younger HIV + participants' performance on memory tasks was qualitatively and quantitatively comparable with that of older HIV − participants, despite the dramatic age difference. Conclusion: Aging and HIV might be additive factors in the expression of cognitive decline. As the HIV + population ages, routine neuropsychological examinations could help clinicians better understand and manage the expression of cognitive impairment.
- 21 September 2012
- Published by Wiley in HIV Medicine
- Vol. 14 (3) , 136-144
Cardiovascular risk factors and carotid intima‐media thickness are associated with lower cognitive performance in HIV‐infected patients
Objectives: The aim of the study was to investigate the relationship between metabolic comorbidities, cardiovascular risk factors or common carotid intima‐media thickness (cIMT) and cognitive performance in HIV‐infected patients.Methods: Asymptomatic HIV‐infected subjects were consecutively enrolled during routine out‐patient visits at two clinical centres. All patients underwent an extensive neuropsychological battery and assessment of metabolic comorbidities and cardiovascular risk factors. Moreover, cIMT was assessed by ultrasonography. Cognitive performance was evaluated by calculating a global cognitive impairment (GCI) score obtained by summing scores assigned to each test (0 if normal and 1 if pathological).Results: A total of 245 patients (median age 46 years; 84.1% with HIV RNA < 50 copies/mL; median CD4 count 527 cells/μL) were enrolled in the study. Cardiovascular risk factors were highly prevalent in our population: the most frequent were dyslipidaemia (61.2%), cigarette smoking (54.3%) and hypertension (15.1%). cIMT was abnormal (≥ 0.9mm) in 31.8% of patients. Overall, the median GCI score was 2 [interquartile range (IQR) 1–4]; it was higher in patients with diabetes (P = 0.004), hypertension (P = 0.030) or cIMT ≥ 0.9 mm (P < 0.001). In multivariate analysis, it was confirmed that diabetes (P = 0.007) and cIMT ≥ 0.9 mm (P = 0.044) had an independent association with lower cognitive performance. In an analysis of patients on combination antiretroviral therapy (cART), abacavir use was independently associated with a better cognitive performance (P = 0.011), while no association was observed for other drugs or neuroeffectiveness score.Conclusions: Diabetes, cardiovascular risk factors and cIMT showed a strong association with lower cognitive performance, suggesting that metabolic comorbidities could play a relevant role in the pathogenesis of HIV‐associated neurocognitive disorders in the recent cART era.
- 21 September 2012
- Published by Wiley in HIV Medicine
- Vol. 14 (3) , 136-144
Cardiovascular risk factors and carotid intima‐media thickness are associated with lower cognitive performance in HIV‐infected patients
Objectives: The aim of the study was to investigate the relationship between metabolic comorbidities, cardiovascular risk factors or common carotid intima‐media thickness (cIMT) and cognitive performance in HIV‐infected patients.Methods: Asymptomatic HIV‐infected subjects were consecutively enrolled during routine out‐patient visits at two clinical centres. All patients underwent an extensive neuropsychological battery and assessment of metabolic comorbidities and cardiovascular risk factors. Moreover, cIMT was assessed by ultrasonography. Cognitive performance was evaluated by calculating a global cognitive impairment (GCI) score obtained by summing scores assigned to each test (0 if normal and 1 if pathological).Results: A total of 245 patients (median age 46 years; 84.1% with HIV RNA < 50 copies/mL; median CD4 count 527 cells/μL) were enrolled in the study. Cardiovascular risk factors were highly prevalent in our population: the most frequent were dyslipidaemia (61.2%), cigarette smoking (54.3%) and hypertension (15.1%). cIMT was abnormal (≥ 0.9mm) in 31.8% of patients. Overall, the median GCI score was 2 [interquartile range (IQR) 1–4]; it was higher in patients with diabetes (P = 0.004), hypertension (P = 0.030) or cIMT ≥ 0.9 mm (P < 0.001). In multivariate analysis, it was confirmed that diabetes (P = 0.007) and cIMT ≥ 0.9 mm (P = 0.044) had an independent association with lower cognitive performance. In an analysis of patients on combination antiretroviral therapy (cART), abacavir use was independently associated with a better cognitive performance (P = 0.011), while no association was observed for other drugs or neuroeffectiveness score.Conclusions: Diabetes, cardiovascular risk factors and cIMT showed a strong association with lower cognitive performance, suggesting that metabolic comorbidities could play a relevant role in the pathogenesis of HIV‐associated neurocognitive disorders in the recent cART era.
- 1 July 2012
- Published by Elsevier in Neuropsychologia
- Vol. 50 (8) , 1980-1989
Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson's disease
- 1 July 2012
- Published by Elsevier in Neuropsychologia
- Vol. 50 (8) , 1980-1989
Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson's disease